Epithelial Expression of Angiogenic Growth Factors Modulate Arterial Vasculogenesis in Human Liver Development
Overview
Authors
Affiliations
Unlabelled: Intrahepatic bile ducts maintain a close anatomical relationship with hepatic arteries. During liver ontogenesis, the development of the hepatic artery appears to be modulated by unknown signals originating from the bile duct. Given the capability of cholangiocytes to produce angiogenic growth factors and influence peribiliary vascularization, we studied the immunohistochemical expression of vascular endothelial growth factor (VEGF), angiopoietin-1, angiopoietin-2, and their cognate receptors (VEGFR-1, VEGFR-2, Tie-2) in fetal human livers at different gestational ages and in mice characterized by defective biliary morphogenesis (Hnf6(-/-)). The results showed that throughout the different developmental stages, VEGF was expressed by developing bile ducts and angiopoietin-1 by hepatoblasts, whereas their cognate receptors were variably expressed by vascular cells according to the different maturational stages. Precursors of endothelial and mural cells expressed VEGFR-2 and Tie-2, respectively. In immature hepatic arteries, endothelial cells expressed VEGFR-1, whereas mural cells expressed both Tie-2 and Angiopoietin-2. In mature hepatic arteries, endothelial cells expressed Tie-2 along with VEGFR-1. In early postnatal Hnf6(-/-) mice, VEGF-expressing ductal plates failed to incorporate into the portal mesenchyma, resulting in severely altered arterial vasculogenesis.
Conclusion: The reciprocal expression of angiogenic growth factors and receptors during development supports their involvement in the cross talk between liver epithelial cells and the portal vasculature. Cholangiocytes generate a VEGF gradient that is crucial during the migratory stage, when it determines arterial vasculogenesis in their vicinity, whereas angiopoietin-1 signaling from hepatoblasts contributes to the remodeling of the hepatic artery necessary to meet the demands of the developing epithelium.
Fan H, Shang J, Li J, Yang B, Zhou D, Jiang S Adv Sci (Weinh). 2025; 12(8):e2407945.
PMID: 39755926 PMC: 11848576. DOI: 10.1002/advs.202407945.
Fetal liver development and implications for liver disease pathogenesis.
Lotto J, Stephan T, Hoodless P Nat Rev Gastroenterol Hepatol. 2023; 20(9):561-581.
PMID: 37208503 DOI: 10.1038/s41575-023-00775-2.
Genetic Factors and Their Role in the Pathogenesis of Biliary Atresia.
Wu L, Zhu Z, Sun L Front Pediatr. 2022; 10:912154.
PMID: 35844731 PMC: 9277099. DOI: 10.3389/fped.2022.912154.
Development of the nervous system in mouse liver.
Koike N, Tadokoro T, Ueno Y, Okamoto S, Kobayashi T, Murata S World J Hepatol. 2022; 14(2):386-399.
PMID: 35317173 PMC: 8891673. DOI: 10.4254/wjh.v14.i2.386.
Role of YAP1 Signaling in Biliary Development, Repair, and Disease.
Molina L, Nejak-Bowen K, Monga S Semin Liver Dis. 2022; 42(1):17-33.
PMID: 35073587 PMC: 9372714. DOI: 10.1055/s-0041-1742277.